Absolutely. I think one of the cornerstones of innovation is being able to not just look inside your company but also to see how best to research and develop and manufacture a vaccine or a medicine. Sometimes that IP exists with another partner. Having those protections protects the collaboration.
On March 23rd, 2023. See this statement in context.